Table 4.
Species, METH dose |
Time-points studied |
Brain area | Data obtained | Reference |
---|---|---|---|---|
BALB/c mice 4 mg/kg × 4 times, every 2 hours | 3 days | Striatum | Microgliosis shown by ↑CD11b immunoreactivity | Asanuma et al. 2004 |
Sprague-Dawley rats 10 mg/kg × 4 times, every 2 hours | 72 hours | Striatum, hippocampus, cerebellum | Microgliosis shown by ↑peripheral benzodiazepine receptor (PBR) density | Escubedo et al. 1998 |
C57BL/6J mice, 30 mg/kg, single i.p. injection | 30’ | Striatum | ↑IL-6 mRNA | Goncalves et al. 2008 |
Hippocampus | ↑TNF-α mRNA | |||
Frontal cortex | ↑IL-6, TNF-α mRNA | |||
1 hour | Striatum, | ↑IL-6 mRNA | ||
Hippocampus | ↑IL-6 mRNA | |||
Frontal cortex | ↑IL-6, TNF-α mRNA | |||
2 hours | Frontal cortex | ↑IL-6 mRNA | ||
C57BL/6J mice, 30 mg/kg, single i.p. injection | 1, 24 hours | Hippocampus | Astrogliosis shown by ↑GFAP immunoreactivity, ↑GFAP protein levels Microgliosis shown by ↑CD11b immunoreactivity, ↑TNFR1 protein levels | Goncalves et al. 2010 |
7 days | Hippocampus | Microgliosis shown by ↑CD11b immunoreactivity, ↑TNF-α protein levels | ||
Wild-type mice 5 mg/kg × 3 times every 3 hours | 1 day | Striatum | Astrogliosis shown by ↑GFAP immunoreactivity, Microgliosis shown by ↑Mac-1 and ↑Iba-1 immunoreactivity, ↑GFAP, ↑Iba-1, ↑TNF-α mRNA, ↑IL-15 immunoreactivity | Granado et al. 2011 |
Sprague-Dawley rats METH exposure for 15 h/day, 8 days METH intake up to 14.5 mg/kg/day | 7 days | Striatum, Cortex | Astrogliosis shown by ↑GFAP protein levels | Krasnova et al. 2010 |
C57BL/6J mice 10 mg/kg × 4 times, every 2 hours | 3, 14 days | Striatum | Microgliosis shown by ↑PBR density | Ladenheim et al. 2000 |
Sprague-Dawley rats 15 mg/kg × 4 times, every 2 hours | 1–6 days | Striatum, parietal cortex, piriform cortex | Microgliosis shown by ↑OX42 immunoreactivity | LaVoie et al. 2004 |
C57BL/6J mice 1 mg/kg, i.p. for 7 days | 72 hours | Striatum | ↑IL-2 mRNA | Loftis et al. 2011 |
Hippocampus | ↑IL-1β, ↑IL-2, ↑IL-6 mRNA | |||
Frontal cortex | ↓IL-1β mRNA | |||
3 weeks | Hippocampus | ↑IL-1β, ↑L-10 mRNA | ||
C57BL/6J X 129Sv/J mice, 45 mg/kg, i.p single injection | 1 hour | Hypothalamus | ↑IL-1β mRNA | Numachi et al. 2007 |
C57BL/6 mice 5 mg/kg × 4 times every 2 hours | 48 hours | Striatum | Astrogliosis shown by ↑GFAP immunoreactivity Microgliosis shown by ↑ILB-4 immunoreactivity | Raineri et al. 2012 |
6 days | Striatum | Astrogliosis shown by ↑GFAP immunoreactivity | ||
Swiss Webster mice 5 mg/kg × 4 times every 2 hours | 12, 24 hours 72 hours | Striatum Striatum | ↑GFAP mRNA Astrogliosis shown by ↑GFAP immunoreactivity | Robson et al. 2014 |
C57BL/6J mice 40 mg/kg single i.p. injection | 12 hours 24 hours 48–72 hours | Striatum | ↑IL-1α mRNA ↑GFAP mRNA Astrogliosis shown by ↑GFAP protein levels | Thomas et al. 2004a |
C57BL/6J mice 10 mg/kg × 4 times, every 2 hours | 24–72 hours | Striatum | Microgliosis shown by ↑ILB4 immunoreactivity | Thomas et al. 2004b |